Westwood N N, Scarcella D L, Bryan-Lluka L J
Department of Physiology and Pharmacology, University of Queensland, Brisbane, Australia.
Naunyn Schmiedebergs Arch Pharmacol. 1996 Apr;353(5):528-35. doi: 10.1007/BF00169172.
Previous pharmacological studies have demonstrated that pulmonary endothelial cells and noradrenergic neurones possess the same transporter for inward transport of catecholamines, uptake1. In noradrenergic neurones, it has been shown that uptake1 is also involved in the carrier-mediated outward transport, or efflux, of noradrenaline and dopamine. The aim of the present study was to examine the efflux of noradrenaline and dopamine from perfused lungs of rats to determine whether uptake1, in addition to diffusion, mediates efflux of catecholamines from pulmonary vascular endothelial cells. The effects of reducing the cellular sodium gradient and of substrates and inhibitors of uptake1 on the efflux of 3H-noradrenaline and 3H-dopamine from rat lungs were measured. Isolated perfused lungs of rats (monoamine oxidase and catechol-O-methyltransferase inhibited) were loaded with 3H-(-)-noradrenaline or 3H-dopamine for 10 min followed by perfusion with either (1) a low sodium, amine-free Krebs solution, in which NaCl was replaced by either Tris.HCl or LiCl, for 15 or 10 min, respectively or (2) amine-free Krebs solution for 30 min in the absence or presence of a substrate or inhibitor of uptake1 for the last 15 min. The rate constants for spontaneous efflux of noradrenaline and dopamine from the lungs were 0.0163 min-1 and 0.0466 min-1, respectively. When NaCl was replaced by Tris.HCl during efflux, the rate constants for efflux of noradrenaline and dopamine were increased 2.5-fold and 3-fold, respectively, whereas, when NaCl was replaced by LiCl, the rate constants were increased 8-fold and 4-fold, respectively. The uptake1 substrates, dopamine (1 and 3 mumol/l) and adrenaline (40 mumol/l), both caused a rapid and marked increase in the efflux of noradrenaline, while noradrenaline (4 mumol/l) had a similar effect on the efflux of dopamine. The uptake1 inhibitors, imipramine (3 and 10 mumol/l) and nisoxetine (50 nmol/l), caused small and gradual increases in the efflux of noradrenaline and dopamine from rat lungs. These results demonstrate that efflux of noradrenaline and dopamine from rat lungs is affected by alterations in the normal sodium gradient across the cell and by drugs that interact with the uptake1 transporter. Thus, it can be concluded that the spontaneous efflux of catecholamines from pulmonary vascular endothelial cells is mediated predominantly by uptake1. In addition, efflux of catecholamines from the lungs has a diffusional component, which, combined with inhibition of reuptake, accounts for the small increase in amine efflux by inhibitors of uptake1.
以往的药理学研究表明,肺内皮细胞和去甲肾上腺素能神经元具有相同的儿茶酚胺内向转运体——摄取1。在去甲肾上腺素能神经元中,已表明摄取1也参与去甲肾上腺素和多巴胺的载体介导的外向转运或流出。本研究的目的是检测大鼠灌注肺中去甲肾上腺素和多巴胺的流出,以确定摄取1除扩散外是否介导肺血管内皮细胞中儿茶酚胺的流出。测定了降低细胞钠梯度以及摄取1的底物和抑制剂对大鼠肺中3H-去甲肾上腺素和3H-多巴胺流出的影响。将大鼠离体灌注肺(单胺氧化酶和儿茶酚-O-甲基转移酶被抑制)用3H-(-)-去甲肾上腺素或3H-多巴胺加载10分钟,然后分别用以下溶液灌注:(1) 低钠、无胺的 Krebs 溶液,其中 NaCl 分别被 Tris.HCl 或 LiCl 替代,持续15或10分钟;或(2) 无胺的 Krebs 溶液30分钟,在最后15分钟不存在或存在摄取1的底物或抑制剂。肺中去甲肾上腺素和多巴胺的自发流出速率常数分别为0.0163分钟-1和0.0466分钟-1。在流出过程中当NaCl被Tris.HCl替代时,去甲肾上腺素和多巴胺的流出速率常数分别增加2.5倍和3倍,而当NaCl被LiCl替代时,速率常数分别增加8倍和4倍。摄取1的底物多巴胺(1和3μmol/L)和肾上腺素(40μmol/L)均导致去甲肾上腺素流出迅速且显著增加,而去甲肾上腺素(4μmol/L)对多巴胺流出有类似作用。摄取1抑制剂丙咪嗪(3和10μmol/L)和尼索西汀(50nmol/L)使大鼠肺中去甲肾上腺素和多巴胺的流出有小幅度且逐渐的增加。这些结果表明,大鼠肺中去甲肾上腺素和多巴胺的流出受跨细胞正常钠梯度的改变以及与摄取1转运体相互作用的药物影响。因此,可以得出结论,肺血管内皮细胞中儿茶酚胺的自发流出主要由摄取1介导。此外,肺中儿茶酚胺的流出有扩散成分,其与再摄取抑制相结合,解释了摄取1抑制剂使胺流出有小幅增加的原因。